Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TOMM22 pseudogene 1 (TOMM22P1)
- Target
- TOMM22P1
- Molecular classification
- Other (Pseudogene)
01
Overview
TOMM22 pseudogene 1 (TOMM22P1) is identified as a pseudogene, meaning it shares sequence similarity with the functional TOMM22 gene but is not believed to code for a functional protein product. There is no evidence that TOMM22P1 expresses a functional protein, plays a direct biological role, is associated with disease, or has drug interactions. Its parent gene TOMM22 is a component of the mitochondrial outer membrane translocase complex and is a true protein-coding gene, but TOMM22P1 is not considered a therapeutic target and has no known functional or pharmacological significance[3][6].
- Other names
- translocase of outer mitochondrial membrane 22 homolog pseudogene 1TOMM22P1
Beyond the preview
Go deeper on TOMM22 pseudogene 1 (TOMM22P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TOMM22 pseudogene 1 (TOMM22P1).